Our findings also indicate that ALKBH5 /m6A axis influences the blood flow recovery and post‐ischemic angiogenesis in hind‐limb ischemia mice, and targeting ALKBH5 might be a potential option to treat ischemic diseases, including PAD. This evidence concerns the gene ALKBH5 and ischemic disease.